Celsion Corporation Restructures its Strategic Loan Facility
Completes New $5 Million Loan Agreement with Market Competitive Terms and Debt Reduction Consistent with Celsion’s CapitalizationNew Agreement Ensures A […]
Mohawk Group Terminates At-the-Market (ATM) Equity Distribution Agreement
NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) — Mohawk Group Holdings, Inc. (NASDAQ: MWK) (“Mohawk”), the tech-enabled, ecommerce consumer products […]
Galectin Therapeutics Appoints Joel Lewis as Chief Executive Officer
Dr. Harold Shlevin retires as CEO, transitions to role of scientific and business consultant and will remain on the BoardBoard […]
Cidara Therapeutics to Participate in Upcoming Investor Conferences
SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to […]
Broadcom Delivers Industry’s First In-band Management Application Reducing the Operational Cost and Complexity of SAN Ownership
SAN JOSE, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) — Broadcom Inc. (NASDAQ: AVGO) today announced the release of Emulex SAN […]
Progenity to Participate in Two Upcoming Investor Conferences
SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record […]
Edison Nation Announces Date of Annual Shareholder Meeting
Bethlehem, PA, Sept. 02, 2020 (GLOBE NEWSWIRE) — Edison Nation, Inc. will conduct its 2020 annual meeting of shareholders on […]
Syneos Health to Present at the Baird 2020 Global Healthcare Conference
MORRISVILLE, N.C., Sept. 02, 2020 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a […]
Kelly® Announces Appointment of New General Counsel
TROY, Mich., Sept. 02, 2020 (GLOBE NEWSWIRE) — Kelly, a global leader in providing workforce solutions, today announced the appointment […]
Otonomy to Participate in Four Upcoming Investor Conferences
SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative […]
